Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate as an Early Treatment Option in Type 1 Diabetes
2019-004434-41Phase 2Completed
- Sponsor
- Flemming Pociot
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Fenofibrate with Placebo (2 arms). Primary endpoint: Change in mean residual insulin secretion measured by C-peptide area. Started Dec 2019; status: completed.
02
Drugs
fenofibrate
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2019-004434-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004434-41.